The ACTA Efficient and Effective Clinical Trial Network Reference Group identified the need for CTNs to maintain trial data for site performance (including recruitment details) and quality control. As a result, a customisable template has been developed that can be used to track trial milestones. This resource can also be useful to identify operational inefficiencies.
Latest Resource
-
ACTA 2021-2022 Annual Report
-
Activities supporting the growth of Clinical Trial Networks in Australia
-
A pilot study to prospectively estimate the health and economic return on research investment
-
ACTA 2020-2021 Annual Report
-
Fundraising strategy: guidance for CTNs
-
Communications and marketing strategy: guidance for CTNs
-
Communications and Marketing for Clinical Trials Networks: Website content management systems (CMS)
-
Communications and Marketing for Clinical Trials Networks: Social Media
-
Communications and Marketing for Clinical Trials Networks: Email Marketing
-
Communications and Marketing for Clinical Trials Networks: Data Dashboards
-
Business Review of CTNs
-
Risk Management: Guidance for Clinical Trial Networks
-
Trial safety oversight: Guidance for Clinical Trial Networks
-
Authorship and Publication Policy: Guidance for Clinical Trial Networks
-
Stakeholder Mapping for Clinical Trial Networks
-
Trial Endorsement and Review: Guidance for CTNs
-
Clinical Trial Network Executive Officer/Network Manager Duties
-
Clinical Trial Network Committee Terms of Reference
-
Establishment of New Clinical Trial Networks: Guidance for CTNs
-
Operational Self-Assessment Tool for CTNs
-
Activities critical to success and growth of Clinical Trials Networks: Sector consultation
-
Clinical Trial Network Strategic Plan Development
-
Clinical Trial Network Membership Structures
-
Clinical Trial Network Governance Structure